Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
24.30
+0.39 (1.64%)
At close: Sep 10, 2025
1.64%
Market Cap60.92M
Revenue (ttm)112.75M
Net Income (ttm)5.83M
Shares Out2.46M
EPS (ttm)2.37
PE Ratio10.45
Forward PEn/a
Dividend0.50 (2.02%)
Ex-Dividend DateSep 11, 2025
Volume1
Average Volume56
Open24.80
Previous Close23.91
Day's Range24.80 - 24.80
52-Week Range18.90 - 32.80
Beta0.18
RSI45.94
Earnings DateNov 14, 2025

About Biogened

Biogened S.A. develops, produces, and distributes pharmaceutical products in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 227
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2024, Biogened's revenue was 110.93 million, an increase of 16.09% compared to the previous year's 95.56 million. Earnings were 5.82 million, an increase of 14.22%.

Financial Statements

News

There is no news available yet.